The Lived Experience: Pulmonary Arterial Hypertension and Intravenous Prostaglandin Therapy
Presentation Type
Oral and/or Visual Presentation
Presenter Major(s)
Nursing
Mentor Information
Patricia Schafer, schaferp@gvsu.edu; Linda Scott, scottl@gvsu.edu
Department
Kirkhof College of Nursing
Location
Kirkhof Center 2216
Start Date
13-4-2011 10:30 AM
End Date
13-4-2011 11:00 AM
Keywords
Health, Illness, and Healing
Abstract
A descriptive phenomenological study proposed to obtain a subjective description of the experience of living with intravenous prostaglandin treatment for pulmonary arterial hypertension. It was intended to determine what kinds of elements are common to the experience, to develop an aggregate structure from the individual descriptions, and add to what is known about this phenomenon. The stories told by participants could help to determine how nurses can assist future patients to live optimally within the confines of a palliative treatment for this incurable illness. No participants responded to recruitment efforts by the researcher. The current state of nursing science about the experience was synthesized. The utility of phenomenological exploration for nursing practice was discussed. Barriers to research recruitment following the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule were examined. Approaches to overcome these barriers were determined.
The Lived Experience: Pulmonary Arterial Hypertension and Intravenous Prostaglandin Therapy
Kirkhof Center 2216
A descriptive phenomenological study proposed to obtain a subjective description of the experience of living with intravenous prostaglandin treatment for pulmonary arterial hypertension. It was intended to determine what kinds of elements are common to the experience, to develop an aggregate structure from the individual descriptions, and add to what is known about this phenomenon. The stories told by participants could help to determine how nurses can assist future patients to live optimally within the confines of a palliative treatment for this incurable illness. No participants responded to recruitment efforts by the researcher. The current state of nursing science about the experience was synthesized. The utility of phenomenological exploration for nursing practice was discussed. Barriers to research recruitment following the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule were examined. Approaches to overcome these barriers were determined.